0001325812-18-000004.txt : 20180108
0001325812-18-000004.hdr.sgml : 20180108
20180108170209
ACCESSION NUMBER: 0001325812-18-000004
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180104
FILED AS OF DATE: 20180108
DATE AS OF CHANGE: 20180108
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Mason Michael
CENTRAL INDEX KEY: 0001514291
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36407
FILM NUMBER: 18517046
MAIL ADDRESS:
STREET 1: 300 3RD STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ALNYLAM PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0001178670
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 770602661
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 300 THIRD STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: (617) 551-8200
MAIL ADDRESS:
STREET 1: 300 THIRD STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
FORMER COMPANY:
FORMER CONFORMED NAME: ALNYLAM PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20020724
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0306
4
2018-01-04
0
0001178670
ALNYLAM PHARMACEUTICALS, INC.
ALNY
0001514291
Mason Michael
300 THIRD STREET
CAMBRIDGE
MA
02142
0
1
0
0
VP, Finance and Treasurer
Common Stock
2018-01-04
4
M
0
1388
42.22
A
6352
D
Common Stock
2018-01-04
4
M
0
1667
63.0
A
8019
D
Common Stock
2018-01-04
4
M
0
3600
88.95
A
11619
D
Common Stock
2018-01-04
4
M
0
2750
96.45
A
14369
D
Common Stock
2018-01-04
4
M
0
2750
96.45
A
17119
D
Common Stock
2018-01-04
4
M
0
10000
97.72
A
27119
D
Common Stock
2018-01-04
4
M
0
6187
96.45
A
33306
D
Common Stock
2018-01-04
4
M
0
3439
63.0
A
36745
D
Common Stock
2018-01-04
4
S
0
5249
130.42
D
31496
D
Common Stock
2018-01-04
4
S
0
16500
131.2
D
14996
D
Common Stock
2018-01-04
4
S
0
12405
132.18
D
2591
D
Common Stock
2018-01-04
4
S
0
1591
132.98
D
1000
D
Common Stock
2018-01-04
4
S
0
400
133.83
D
600
D
Common Stock
2018-01-04
4
S
0
600
135.0
D
0
D
Common Stock
226
I
by Managed Account
Performance Stock Option 2013 (right to buy)
63.0
2018-01-04
4
M
0
1667
0.0
D
2017-09-20
2023-12-17
Common Stock
1667
0
D
Performance Stock Option 2014 (right to buy)
96.45
2018-01-04
4
M
0
2750
0.0
D
2016-02-01
2024-12-17
Common Stock
2750
2750
D
Performance Stock Option 2014 (right to buy)
96.45
2018-01-04
4
M
0
2750
0.0
D
2017-07-07
2024-12-17
Common Stock
2750
0
D
Stock Option (right to buy)
42.22
2018-01-04
4
M
0
1388
0.0
D
2026-12-20
Common Stock
1388
4162
D
Stock Option (right to buy)
63.0
2018-01-04
4
M
0
3439
0.0
D
2023-12-18
Common Stock
3439
0
D
Stock Option (right to buy)
88.95
2018-01-04
4
M
0
3600
0.0
D
2025-12-18
Common Stock
3600
3600
D
Stock Option (right to buy)
96.45
2018-01-04
4
M
0
6187
0.0
D
2024-12-17
Common Stock
6187
2063
D
Stock Option (right to buy)
97.72
2018-01-04
4
M
0
10000
0.0
D
2015-12-07
2025-12-07
Common Stock
10000
0
D
All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 2, 2017.
Sale prices ranged from $129.74 to $130.72.
Sale prices ranged from $130.74 to $131.73.
Sale prices ranged from $131.75 to $132.71.
Sale prices ranged from $132.75 to $133.71.
Sale prices ranged from $133.78 to $134.11.
Sale prices ranged from $134.94 to $135.10
The reporting person owns 226 shares of ALNY common stock under the ALNY 401(k) plan as a result of the ALNY 401(k) matching contribution program.
The stock option vests as to 25% of the shares on the 1st anniversary of the date of the stock option grant and as to an additional 6.25% of the shares each successive three month period thereafter.
/s/ Michael P. Mason
2018-01-08